论文信息 - Nodal/Activin signaling: a novel target for pancreatic cancer stem cell therapy. - 字舞流文

Nodal/Activin signaling: a novel target for pancreatic cancer stem cell therapy.

D. Dawson | T. Donahue

[1] T. Welling,et al. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. , 2011, Gastroenterology.

[2] Manuel Hidalgo,et al. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. , 2011, Cell stem cell.

[3] Henry Yang,et al. Graded Nodal/Activin Signaling Titrates Conversion of Quantitative Phospho-Smad2 Levels into Qualitative Embryonic Stem Cell Fate Decisions , 2011, PLoS genetics.

[4] Malte Buchholz,et al. Stromal biology and therapy in pancreatic cancer , 2010, Gut.

[5] Maria Cristina Rangel,et al. Role of Cripto-1 in stem cell maintenance and malignant progression. , 2010, The American journal of pathology.

[6] P. Tam,et al. Extrinsic regulation of pluripotent stem cells , 2010, Nature.

[7] J. D'haese,et al. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. , 2009, Gastroenterology.

[8] D. Simeone,et al. Human pancreatic cancer stem cells: implications for how we treat pancreatic cancer. , 2008, Translational oncology.

[9] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[10] B. Petersen,et al. AUTOIMMUNE PANCREATITIS: DIAGNOSIS USING HISTOLOGY, IMAGING, SEROLOGY, OTHER ORGAN INVOLVEMENT AND RESPONSE TO STEROIDS , 2005 .